Company recommends alternative devices for patients who can tolerate treatment interruptions.
The recall does not include removal of the devices from the market; instead, it provides instructions for correcting the devices in the event of interruptions in or loss of therapy. The updated use instructions apply to the Philips Respironics’ BiPAP A30, BiPAP A40, and BiPAP V30 Auto, all lots, according to the statement.
The company is issuing updated instructions because of the risk for potential failure in the ventilator inoperative alarm. This failure can cause interruption or loss of therapy and has been associated with 13 injuries and 8 deaths. The devices are designed to provide noninvasive breathing support for adults and children who weigh more than 22 pounds with obstructive sleep apnea and respiratory insufficiency. According to the statement, any of the affected devices may reboot intermittently, meaning a 5-10 second period of no therapy, with a blank screen and a single audible alert. The devices may then restart with the same patient settings, or they may reboot intermittently and restart with their factory default settings. Additionally, the devices have been reported to enter a “ventilator inoperative” state during which therapy stops and audible and visual alarms are present. “These issues can result in therapy interruption or loss, potentially leading to hypoventilation, hypoxemia, hypercarbia, respiratory failure, or death in vulnerable patients,” according to the statement. The BiPAP A30 and BiPAP A40 are suitable for home use and clinical use; the BiPAP V30 Auto is for use in hospitals or institutions. If the ventilator inoperative alarm occurs, patients who can tolerate interruptions of therapy should be placed on an alternative device; patients who can’t tolerate a therapy interruption should be given alternate ventilation, and clinicians should contact their equipment supplier for an immediate device alternative, according to the recall. A hard reboot may temporarily restore the device, according to the statement.Commenting is limited to medical professionals. To comment please . Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see ourHow Effective Is Nirsevimab in Preventing Severe RSV-Related Infections?
Ventilator Medical Ventilator Sleep Apnea Sleep Apnoea Sleep Disturbance Abnormal Sleep Pattern Sleep Disorders Somnipathy U.S. Food And Drug Administration United States Food And Drug Administration FDA Food And Drug Administration (FDA) Food And Drug Administration Obstructive Sleep Apnea
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
21 children birthed by surrogate mothers found in Arcadia homeDarsha Philips is a reporter for NBC Los Angeles.
Read more »
Philips shares up 8% as health tech giant flags reduced U.S. tariff impactJoin CNBC for the latest news on what’s moving European markets.
Read more »
Philips shares up 10% as health tech giant flags reduced U.S. tariff impactJoin CNBC for the latest news on what's moving European markets.
Read more »
Tennessee executes man with implanted heart device despite concerns over shock riskByron Black's execution marked the first time a man has been put to death with a working defibrillator in his chest, experts say.
Read more »
Tesla Patents Bizarre Sucking DeviceScience and Technology News and Videos
Read more »
Look at the pre-smartphone era mobile device found in a T-Mobile officeAlan, an ardent smartphone enthusiast and a veteran writer at PhoneArena since 2009, has witnessed and chronicled the transformative years of mobile technology. Owning iconic phones from the original iPhone to the iPhone 15 Pro Max, he has seen smartphones evolve into a global phenomenon.
Read more »